Tuesday, August 9, 2022

Axonics® Launches Direct to Client Tv Promoting Marketing campaign

Must read

IRVINE, Calif.–()–Axonics, Inc. (Nasdaq: AXNX), a world medical expertise firm that’s growing and commercializing novel merchandise for the therapy of bladder and bowel dysfunction, at the moment introduced the launch of its direct to client tv promoting marketing campaign.

The Discover Actual Aid marketing campaign is concentrated on girls with any type of urinary incontinence, a big and considerably undertreated inhabitants. The marketing campaign goals to cut back the stigma related to these situations, elevate consciousness of the Axonics model and therapies, and encourage girls to seek the advice of a bladder specialist.

The commercials characteristic girls with urinary incontinence which were handled with Axonics sacral neuromodulation (SNM) remedy after consulting with their doctor. The ladies communicate authentically concerning the challenges of residing with incontinence and the way Axonics has supplied them life-changing symptom reduction.

The commercials encourage viewers to go to FindRealRelief.com, Axonics’ new patient-facing touchdown web page. This web site gives details about Axonics’ incontinence options and directs people to finish a brief symptom quiz. Certified people will then be contacted by a workforce of nurses in an effort to attach the individual to a specialist doctor of their group.

The commercials at the moment are airing on tv in over 40 markets throughout america and are scheduled to run by the top of the yr. Through the month of Might, the commercials will probably be featured on nationwide tv throughout packages that price extremely with the goal demographic. The Discover Actual Aid marketing campaign will even embrace focused promoting on YouTube, Fb, digital audio, and numerous web sites.

“Tens of tens of millions of Individuals endure from urinary incontinence and wrestle to seek out long-term symptom reduction,” stated John Woock, Ph.D., govt vice chairman, chief advertising and marketing and technique officer of Axonics. “The corporate is making this vital funding as a result of we’re dedicated to this affected person inhabitants and it’s important that Individuals affected by incontinence have the chance to seek out reduction for his or her signs. Our omnichannel technique will set up the Axonics model and permit us to have interaction adults with incontinence throughout a number of platforms with a constant message that new, life-changing incontinence therapies can be found to them. We’re excited to launch this tv promoting marketing campaign and we’re assured that it’ll proceed to drive SNM market enlargement and advance Axonics on its path to market management.”

About Axonics

Based mostly in Irvine, Calif., Axonics is a world medical expertise firm that’s growing and commercializing novel merchandise for adults with bladder and bowel dysfunction. Axonics just lately ranked No. 1 on the 2021 Deloitte Know-how Quick 500™, a rating of the five hundred fastest-growing expertise, media, telecommunications, life sciences, fintech, and vitality tech firms in North America.

The corporate’s sacral neuromodulation (SNM) techniques present sufferers affected by overactive bladder and/or fecal incontinence with long-lived, simple to make use of, protected, clinically efficient remedy. As well as, Axonics’ best-in-class urethral bulking hydrogel, Bulkamid®, gives protected and sturdy symptom reduction to girls with stress urinary incontinence (SUI). Overactive bladder impacts an estimated 87 million adults within the U.S. and Europe, with a further 40 million adults estimated to endure from fecal incontinence. SUI impacts an estimated 29 million girls within the U.S. alone. Axonics’ clinically confirmed merchandise are supplied at lots of of medical facilities throughout the U.S. and overseas. Reimbursement protection is effectively established within the U.S. and is a lined service in most European nations. For extra info, go to www.axonics.com.

Ahead-Wanting Statements

Statements made on this press launch that relate to future plans, occasions, prospects or efficiency are forward-looking statements as outlined beneath the Non-public Securities Litigation Reform Act of 1995. Phrases reminiscent of “deliberate,” “expects,” “believes,” “anticipates,” “designed,” and related phrases are supposed to determine forward-looking statements. Whereas these forward-looking statements are based mostly on the present expectations and beliefs of administration, such forward-looking statements are topic to a variety of dangers, uncertainties, assumptions and different elements that might trigger precise outcomes to vary materially from the expectations expressed on this press launch, together with the dangers and uncertainties disclosed in Axonics filings with the Securities and Change Fee, all of which can be found on-line at www.sec.gov. Readers are cautioned to not place undue reliance on these forward-looking statements, which communicate solely as of the date hereof. Besides as required by legislation, Axonics undertakes no obligation to replace or revise any forward-looking statements to replicate new info, modified circumstances or unanticipated occasions.

Supply hyperlink

More articles


Please enter your comment!
Please enter your name here

Latest article